217 / 1631
Cardiovascular disease after therapy for HL:
A detailed analysis of 9 collaborative EORTC-LYSA trials
•
Incidence of CVD was reported during follow-up and
updated through a patient-reported questionnaire,
mailed in 2009–2010
Maraldo et al, Lancet Hemat 2015